secwatch.observer — SEC 8-K summary
======================================

Issuer:     Encompass Health Corp (EHC)
CIK:        0000785161
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0000785161-24-000015
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Encompass Health reiterates FY2024 guidance at Barclays conference; no changes
------------------------------------------------------------------------------

- Company to present at Barclays Global Healthcare Conference on March 12, 2024, with CEO and CFO.
- Reaffirms FY2024 guidance: net operating revenue $5,200M-$5,300M.
- Adjusted EBITDA reaffirmed at $1,015M-$1,055M; adjusted EPS $3.77-$4.06.
- Guidance unchanged from Feb 7 8-K and Feb 8 earnings call.
- No new financial or operational updates disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/785161/000078516124000015/0000785161-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/785161/000078516124000015/ehc-20240311.htm
  HTML page:      https://secwatch.observer/filing/0000785161-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer